TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19056011

Group type: EXPERIMENTAL
Intervention: Drotrecogin α (activated) treatment
Number of subjects: 1

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 1
Study: 16162207

Group type: EXPERIMENTAL
Intervention: Adenovirus infection detection using PCR on plasma samples
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Liver transplant
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Kidney transplant
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Heart transplant
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Time to viremia onset
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Symptoms at time of viremia
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Recovery from adenovirus infection
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Subsequent acute rejection
Number of subjects: 263
Study: 14572189

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 180

Group type: COMPARATOR
Intervention: Nonalcoholic beverage
Number of subjects: 180
Study: 9473994

Group type: EXPERIMENTAL
Intervention: Rehabilitation services for 5 hours, 1 day per week, over 1 year
Number of subjects: 46

Group type: COMPARATOR
Intervention: Waiting list (nontreatment comparison group)
Number of subjects: 46
Study: 7603811

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil suspension (20 mg/kg/day twice daily for 4 days)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Penicillin suspension (45 mg/kg/day divided three times daily for 10 days)
Number of subjects: 308
Study: 2168908

Group type: EXPERIMENTAL
Intervention: Group 1 (19 patients followed for 16 months)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Group 2 (7 patients with more advanced disease)
Number of subjects: 26
Study: 638248

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: RT+CT
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Nodal relapse
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Bone marrow relapse
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Nodal disease
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Bone marrow involvement
Number of subjects: 244
Study: 31283796

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 60
Study: 28514299

Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal patch
Number of subjects: 96

Group type: COMPARATOR
Intervention: Parecoxib intravenous injection (Group A)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Oral celecoxib (Group B)
Number of subjects: 96
Study: 26573452

Group type: EXPERIMENTAL
Intervention: Acupressure (20 intermittent presses to stimulate Large Intestine 4 and Spleen 6)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Sham treatment (20 intermittent presses to the patella and olecranon)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 132
Study: 24205115

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus CNCM I‐4036
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve CNCM I‐4035
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei CNCM I‐4034, Bifidobacterium breve CNCM I‐4035, Lactobacillus rhamnosus CNCM I‐4036
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 21544022

Group type: EXPERIMENTAL
Intervention: SensaScope
Number of subjects: 24

Group type: COMPARATOR
Intervention: Macintosh 3 laryngoscope
Number of subjects: 24
Study: 18523893

Group type: EXPERIMENTAL
Intervention: Standardized advice and a dose tapering schedule
Number of subjects: 135

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 135
Study: 16557206

Group type: EXPERIMENTAL
Intervention: PET using fluorine-18 fluorodeoxyglucose (FDG)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Dual-head coincidence gamma camera (CGC-I)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Conventional imaging (CI)
Number of subjects: 151
Study: 14627859

Group type: EXPERIMENTAL
Intervention: 17beta-estradiol gel 2.5 g (1.5 mg estradiol)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: 17beta-estradiol gel 1.25 g (0.75 mg estradiol)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: All groups (17beta-estradiol gel 2.5 g, 17beta-estradiol gel 1.25 g, placebo)
Number of subjects: 221
Study: 11566168

Group type: EXPERIMENTAL
Intervention: 10‐mg atorvastatin
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9569657

Group type: EXPERIMENTAL
Intervention: Trait anxiety
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Impulsivity
Number of subjects: 0
Study: 8053744

Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented TPN (0.18 g of glutamine/kg/d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional TPN (0.2 g nitrogen/kg/d)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented TPN
Number of subjects: 20
Study: 2965375

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (CY 222) at a fixed dose of 750 anti-Xa units
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard heparin at a dose of 500 IU/kg/24 h
Number of subjects: 68
Study: 8345416

Group type: EXPERIMENTAL
Intervention: Somatotropin, 0.3 mg/kg per week, administered subcutaneously three times weekly (n = 63)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Daily dosing of somatotropin (n = 92)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Three-times-weekly dosing of somatotropin (n = 92)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Somatotropin (n = 92)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Nontreatment control subjects (n = 58)
Number of subjects: 121
Study: 76842

Group type: EXPERIMENTAL
Intervention: Phenylalanine mustard (P.A.M.)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Combination of cyclophosphamide, 5‐fluorouracil, and prednisone (C.F.P.) with or without radiotherapy
Number of subjects: 172
Study: 29881917

Group type: EXPERIMENTAL
Intervention: Fortified milk
Number of subjects: 119

Group type: COMPARATOR
Intervention: Regular full milk (control)
Number of subjects: 119
Study: 28511620

Group type: EXPERIMENTAL
Intervention: Typical voice condition
Number of subjects: 93

Group type: COMPARATOR
Intervention: Dysphonic voice condition
Number of subjects: 93
Study: 26666258

Group type: EXPERIMENTAL
Intervention: MEDI-551, a monoclonal antibody that depletes CD19+ B-cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24438695

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (group B)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Three-dimensional conformal radiotherapy alone (group A)
Number of subjects: 98
Study: 22712881

Group type: EXPERIMENTAL
Intervention: 6-month self-management program led by an Exercise Specialist
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 110
Study: 19589822

Group type: EXPERIMENTAL
Intervention: Unsupervised home based proprioceptive training programme
Number of subjects: 522

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 522
Study: 17628642

Group type: EXPERIMENTAL
Intervention: Potentized homeopathic remedy Arsenicum Album-30
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (Succussed Alcohol-30)
Number of subjects: 25
Study: 14747397

Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 72

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 72
Study: 12021573

Group type: COMPARATOR
Intervention: Tezosentan 100 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Tezosentan 200 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Tezosentan 400 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Tezosentan 600 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Tezosentan (all doses)
Number of subjects: 6
Study: 9826295

Group type: EXPERIMENTAL
Intervention: Children with schizophrenia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children with ADHD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Age-matched normal children
Number of subjects: 0
Study: 8007742

Group type: EXPERIMENTAL
Intervention: L-Thyroxin Henning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Another tablet preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral solution of levothyroxine (reference solution)
Number of subjects: 0
Study: 2509007

Group type: EXPERIMENTAL
Intervention: Calcitonin treatment (100 U by subcutaneous self-application on alternate days for 6-8 weeks)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cyclical hormone replacement therapy (over 12 months)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (analgetic treatment and 500 mg Ca daily)
Number of subjects: 28
Study: 1099526

Group type: EXPERIMENTAL
Intervention: 300 mg of ASA
Number of subjects: 50

Group type: COMPARATOR
Intervention: 100 mg of lactose (placebo)
Number of subjects: 50
Study: 29932001

Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 37

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 37
Study: 28517112

Group type: COMPARATOR
Intervention: Usual care arm participants of a randomized clinical trial
Number of subjects: 91
Study: 25932260

Group type: COMPARATOR
Intervention: memantine + placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: memantine + huperzine A
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: memantine + donepezil
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: memantine + rivastigmine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: memantine + galantamine
Number of subjects: 110
Study: 23553060

Group type: EXPERIMENTAL
Intervention: Normal Saline (NS) lock
Number of subjects: 802

Group type: COMPARATOR
Intervention: Heparin lock (300 U/3 ml)
Number of subjects: 802
Study: 22212315

Group type: EXPERIMENTAL
Intervention: Patient-controlled epidural analgesia (PCEA) with pure ropivacaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intermittent bolus epidural of 2 mg/10 mL morphine
Number of subjects: 120
Study: 19638112

Group type: EXPERIMENTAL
Intervention: General anesthesia with sevoflurane (GAS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: General anesthesia with propofol (GAP)
Number of subjects: 200
Study: 16449474

Group type: EXPERIMENTAL
Intervention: Recovery from bipolar disorder
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Depressive episodes
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Manic, hypomanic, or mixed episodes
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Time to depressive episode
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Time to manic/hypomanic/mixed episode
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Residual depressive or manic symptoms
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Proportion of days depressed or anxious
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Proportion of days of elevated mood
Number of subjects: 1469
Study: 15385829

Group type: EXPERIMENTAL
Intervention: 2 mg of micronized 17beta‐estradiol valerate (E2V)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 2 mg of E2V in combination with 5 mg of medroxyprogesterone acetate (MPA)
Number of subjects: 15
Study: 11041770

Group type: EXPERIMENTAL
Intervention: Use of the World Wide Web for patient randomization and data collection
Number of subjects: 31
Study: 9410554

Group type: EXPERIMENTAL
Intervention: Lispro insulin analog
Number of subjects: 189
Study: 1564646

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bupivacaine with epinephrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain Lidocaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain Bupivacaine
Number of subjects: 0
Study: 3896085

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 24 months
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo for 24 months
Number of subjects: 170
Study: 29941030

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard wound management
Number of subjects: 20
Study: 28531281

Group type: EXPERIMENTAL
Intervention: INT‐HF‐MP (intensified heart failure management programme)
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: INT‐HF‐MP
Number of subjects: 787

Group type: COMPARATOR
Intervention: SM (standard management)
Number of subjects: 787
Study: 26005255

Group type: EXPERIMENTAL
Intervention: Cystectomy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Puncture with endocoagulation
Number of subjects: 60
Study: 26862625

Group type: EXPERIMENTAL
Intervention: Fentanyl-bupivacaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fentanyl-bupivacaine-morphine
Number of subjects: 0
Study: 21964681

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Titanium tacks
Number of subjects: 40
Study: 18986288

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 16645357

Group type: EXPERIMENTAL
Intervention: Valsartan (titrated up to 320 mg)
Number of subjects: 1402

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1402
Study: 12813377

Group type: EXPERIMENTAL
Intervention: Mitral valve plasty (MVP)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Mitral valve replacement (MVR)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Mitral valve plasty (MVP) and Mitral valve replacement (MVR)
Number of subjects: 225
Study: 10930160

Group type: EXPERIMENTAL
Intervention: MOS-HIV questionnaire
Number of subjects: 296

Group type: COMPARATOR
Intervention: MQOL-HIV questionnaire
Number of subjects: 296
Study: 8912074

Group type: EXPERIMENTAL
Intervention: Early definitive treatment with antrectomy or pyloroplasty
Number of subjects: 36

Group type: COMPARATOR
Intervention: Gastrostomy plus feeding jejunostomy
Number of subjects: 36
Study: 1703618

Group type: EXPERIMENTAL
Intervention: Reverse-transcriptase (RT)/PCR
Number of subjects: 40

Group type: COMPARATOR
Intervention: Solid-phase enzyme immunoassay
Number of subjects: 40
Study: 7004479

Group type: EXPERIMENTAL
Intervention: Timolol eyedrops followed by adrenaline
Number of subjects: 20
Study: 31137959

Group type: EXPERIMENTAL
Intervention: Weekly real-time adherence feedback via SMS using Wisepill device
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Text messaging intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group adherence feedback
Number of subjects: 0
Study: 30077599

Group type: EXPERIMENTAL
Intervention: Stair-stepping bouts for 1, 3, and 10 minutes
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Stair-stepping bouts for 10 minutes
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Stair-stepping bouts for 3 minutes
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Stair-stepping bouts
Number of subjects: 34
Study: 25546482

Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation (VR)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study: 26241434

Group type: EXPERIMENTAL
Intervention: Burch colposuspension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autologous fascial sling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Retropubic midurethral sling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transobturator midurethral sling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midurethral sling groups (combined)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall surgical intervention
Number of subjects: 0
Study: 23188739

Group type: EXPERIMENTAL
Intervention: Related word pairs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unrelated word pairs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disrupted fluency by presenting pairs in an alternating format (Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measured conceptual fluency (Experiment 3)
Number of subjects: 0
Study: 22319901

Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga for two months
Number of subjects: 26
Study: 19541792

Group type: EXPERIMENTAL
Intervention: Oral casopitant 50 mg
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Oral casopitant 100 mg
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Oral casopitant 150 mg
Number of subjects: 493

Group type: COMPARATOR
Intervention: Control (ondansetron/dexamethasone)
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Single oral casopitant 150 mg
Number of subjects: 493
Study: 16510744

Group type: EXPERIMENTAL
Intervention: Natalizumab (300 mg, intravenous infusion every four weeks for more than two years)
Number of subjects: 942

Group type: COMPARATOR
Intervention: Placebo (intravenous infusion every four weeks for more than two years)
Number of subjects: 942
Study: 12752404

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN) intravenous infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo intravenous infusion
Number of subjects: 8
Study: 10956377

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine, glutathione, alpha-lipoic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-glutamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-carnitine and acetyl-L-carnitine
Number of subjects: 0
Study: 8360397

Group type: EXPERIMENTAL
Intervention: Urea as a marker for ELF volume
Number of subjects: 0
Study: 3533564

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 29968301

Group type: EXPERIMENTAL
Intervention: salbutamol (6 × 4 mg oral)
Number of subjects: 12
Study: 27054610

Group type: EXPERIMENTAL
Intervention: Agomelatine 25-50mg/day
Number of subjects: 287

Group type: COMPARATOR
Intervention: Escitalopram 10-20mg/day
Number of subjects: 287
Study: 25823155

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 100
Study: 22868970

Group type: EXPERIMENTAL
Intervention: Warmed humidified CO₂ (30 °C, 93 % rH)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard warming measures (Control)
Number of subjects: 80
Study: 21084036

Group type: EXPERIMENTAL
Intervention: rHuEPO plus oral oxymetholone (50 mg/tablet twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: rHuEPO plus placebo
Number of subjects: 24
Study: 18958840

Group type: EXPERIMENTAL
Intervention: Atorvastatin monotherapy
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Atorvastatin and pioglitazone combined treatment
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Combined treatment with atorvastatin and pioglitazone
Number of subjects: 148
Study: 15973180

Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation
Number of subjects: 255
Study: 12088775

Group type: EXPERIMENTAL
Intervention: Cardiovascular Magnetic Resonance (CMR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2-Dimensional Echocardiography
Number of subjects: 60
Study: 10492293

Group type: EXPERIMENTAL
Intervention: Music during bronchoscopy
Number of subjects: 60

Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 60
Study: 8971229

Group type: EXPERIMENTAL
Intervention: Wrist orthoses (3 styles)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Unsplinted condition
Number of subjects: 42
Study: 1348641

Group type: EXPERIMENTAL
Intervention: Combined epidural and general anaesthesia with spontaneous ventilation
Number of subjects: 80

Group type: COMPARATOR
Intervention: General anaesthesia with muscle relaxation and ventilation
Number of subjects: 80
Study: 3968013

Group type: EXPERIMENTAL
Intervention: Graded elastic (E) loads
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Graded resistive (R) loads
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Graded R in the presence of elevated background R
Number of subjects: 5
Study: 30870770

Group type: EXPERIMENTAL
Intervention: ¡Aptívate! (n = 22)
Number of subjects: 42

Group type: COMPARATOR
Intervention: iCouch CBT (active control; n = 9)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU; n = 11)
Number of subjects: 42
Study: 29161988

Group type: EXPERIMENTAL
Intervention: FIFA 11 for Health programme (2×45 minutes per week)
Number of subjects: 931

Group type: COMPARATOR
Intervention: Obligatory daily school-based physical activity (5×45 minutes per week)
Number of subjects: 931
Study: 26886651

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading of 1.0 μg/kg for 20 minutes before the termination of surgery)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (comparable volume of normal saline)
Number of subjects: 100
Study: 24576512

Group type: EXPERIMENTAL
Intervention: Faith-based therapeutic lifestyle change (TLC) intervention delivered through 11 weekly sessions and 3 monthly motivational interviewing sessions.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Health education (HE) control delivered through 11 weekly classes on hypertension and other health topics.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Faith-based TLC intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Health education (HE) control
Number of subjects: 0
Study: 23383460

Group type: EXPERIMENTAL
Intervention: Belt Vessel (Daimai) Regulation Acupoint Recipe with electroacupuncture applied to bilateral GB 26 and ST 25, treatment conducted once every other day for 8 weeks
Number of subjects: 35
Study: 20429832

Group type: EXPERIMENTAL
Intervention: 4 mm x 32G pen needle
Number of subjects: 173

Group type: COMPARATOR
Intervention: 5 mm x 31G pen needle
Number of subjects: 173

Group type: COMPARATOR
Intervention: 8 mm x 31G pen needle
Number of subjects: 173
Study: 18848937

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48